2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°Á : 2024-06-23 |
|
2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°Á : 2024-06-23 ±³À°ÁÖÁ¦ : 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°Á ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ ´ã´çÀÚ : À¯ÀçÈñ À̸ÞÀÏ : kstr2014@gmail.com ±³À°Á¾·ù : ¿µ»óÀÇÇаú Âü¼®¿¹»óÀÎ : 250¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 80,000¿ø ºñ°í Àü°øÀÇ 3¸¸¿ø, Àü¹®ÀÇ 8¸¸¿ø, Á¤È¸¿ø 1¸¸¿ø
±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 09:05~09:25 Early pulmonary fibrosis: Why is it important Luca Richeldi(Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 09:25~09:45 Interstitial lung abnormalities: A radiologist Hiroto Hatabu(Brigham and Women¡¯s Hospital) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 09:45~09:55 ÁúÀÇÀÀ´ä () ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 09:55~10:20 Progressive pulmonary fibrosis: Current issues Kevin Brown(National Jewish Health) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 10:20~10:40 Therapy of pulmonary fibrosis: 2024 and beyond Luca Richeldi(Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 10:40~10:50 ÁúÀÇÀÀ´ä () ÈÞ½Ä 06¿ù 23ÀÏ 10:50~11:00 ÈÞ½Ä () ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 11:00~11:20 Clinical application of recent clinical practice guidelines for IPF and HP Christopher Ryerson(University of British Columbia & St. Paul¡¯s Hospital) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 11:20~11:40 CTD-associated ILD Kevin Brown(National Jewish Health) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 11:40~11:50 ÁúÀÇÀÀ´ä () ½Ä»ç 06¿ù 23ÀÏ 11:50~13:00 ½Ä»ç () ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 13:00~13:25 Lymphangioleiomyomatosis and Pulmonary Langerhans Cell Histiocytosis Yoshikazu Inoue(National Hospital Organization Kinki-Chuo Chest Medical Center / Osaka Anti-tuberculosis Association Osaka Fukujuji Hospital) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 13:25~13:45 Drug-related pneumonitis related to targeted therapy and immunotherapy Mizuki Nishino(Brigham and Women¡¯s Hospital) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 13:45~14:05 CT phenotyping of sarcoidosis David Lynch(National Jewish Health) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 14:05~14:15 ÁúÀÇÀÀ´ä () ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 14:15~14:35 Broad spectrum of obstructive lung diseases: Beyond COPD and asthma Jay Ryu(Mayo Clinic - Rochester) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 14:35~14:50 Insight into CT-detected mucus plugs in COPD Raul San Jose Estepar(Brigham and Women¡¯s Hospital) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 14:50~15:10 Small airways disease: Bronchiolar disorders Jay Ryu(Mayo Clinic - Rochester) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 15:10~15:20 ÁúÀÇÀÀ´ä () ÈÞ½Ä 06¿ù 23ÀÏ 15:20~15:30 ÈÞ½Ä () ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 15:30~15:50 CT quantification of pulmonary fibrosis Joon Beom Seo(Asan Medical Center - University of Ulsan College of Medicine) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 15:50~16:05 Assessment of vascular morphology and perfusion Raul San Jose Estepar(Brigham and Women¡¯s Hospital) ±³À°½Ã°£ 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 16:05~16:20 Deep learning classification of fibrotic lung disease David Lynch(National Jewish Health) Åä·Ð 06¿ù 23ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø CJ Ȧ 16:20~16:30 ÁúÀÇÀÀ´ä ()
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|